Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Telsey Advisory Group Downgrades Bed Bath & Beyond to Underperform, Lowers Price Target to $15

Telsey Advisory Group analyst Joseph Feldman downgrades Bed Bath & Beyond (NASDAQ:BBBY) from Market Perform to Underperform and lowers the price target from $18 to $15.

byBenzinga Newsdesk

April 14, 2022

1 minute read

Telsey Advisory Group analyst Joseph Feldman downgrades Bed Bath & Beyond (NASDAQ:BBBY) from Market Perform to Underperform and lowers the price target from $18 to $15.

Didi Global Expected to Price IPO at Top of Range of $13 to $14/Share or Above

By Charles Gross

Today, 6:03 AM

-Reuters https://www.reuters.com/business/didi-flags-ipo-share-price-top-range-or-above-source-2021-06-29/

DIDI

If You Invested $1000 In This Stock 5 Years Ago, Here’s How Much You Would Have Today

By Benzinga Insights

Today, 6:03 AM

American Water Works Co (NYSE:AWK) has outperformed the market over the past 5 years by 3.86% on an annualized basis.

AWK

Legal
News

Sesen Bio, Qilu Pharmaceutical Announce Enrollment Of First Patient In Clinical Trial For Vicineum In China

By Benzinga Newsdesk

Today, 6:03 AM

Sesen Bio (NASDAQ:SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, and its partner in Greater China, Qilu Pharmaceutical, announced

SESN